Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CB-0135 by Cosmo Pharmaceuticals for Proctitis: Likelihood of Approval
CB-0135 is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Proctitis. According to GlobalData, Phase II...
Data Insights
CB-0135 by Cosmo Pharmaceuticals for Limited/Distal Colitis: Likelihood of Approval
CB-0135 is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Limited/Distal Colitis. According to GlobalData, Phase...